Anna Dickson, PhD, is a Senior Scientist at AstraZeneca, where they focus on Cell Biology and Immunology. They completed their PhD in Medical Science at the University of Cambridge, where their research utilized CRISPR/Cas9 technology to study protein quality control. Previously, Anna gained valuable experience as a Science Policy Intern at The Royal Society and as a Vice Chair for the Building Bridges in Medical Science Conference. With a robust academic foundation, including a First Class Honours degree in Biomedical Sciences from The University of Manchester, Anna is passionate about translating scientific research into clinical applications.
This person is not in the org chart
This person is not in any teams
This person is not in any offices